Safety and Efficacy of Gevokizumab in Patients with Behcet's Disease Uveitis: Results of an Exploratory Phase 2 Study


Tugal-Tutkun I., KADAYIFÇILAR S. , Khairallah M., Lee S. C. , Ozdal P., Ozyazgan Y., ...Daha Fazla

OCULAR IMMUNOLOGY AND INFLAMMATION, cilt.25, ss.62-70, 2017 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 25 Konu: 1
  • Basım Tarihi: 2017
  • Doi Numarası: 10.3109/09273948.2015.1092558
  • Dergi Adı: OCULAR IMMUNOLOGY AND INFLAMMATION
  • Sayfa Sayıları: ss.62-70

Özet

Purpose: To evaluate the safety and efficacy of gevokizumab for the treatment of Behcet's disease uveitis in a prospective, open-label, randomized phase 2 trial.